Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor.
Takeda
Tomohiro
T
Department of Pediatrics, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
Sakurai
Yoshihiko
Y
Tatsumi
Kohei
K
Kato
Junko
J
Kasuda
Shogo
S
Yoshioka
Akira
A
Shima
Midori
M
D000293:Adolescent; D000328:Adult; D001323:Autoantibodies / Q000097:blood*; D053264:B-Cell Activating Factor / Q000097:blood*; D016022:Case-Control Studies; D002648:Child; D002675:Child, Preschool; D004797:Enzyme-Linked Immunosorbent Assay; D005169:Factor VIII / Q000276:immunology*; D006467:Hemophilia A / Q000097:blood* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007223:Infant; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13 / Q000097:blood; D015854:Up-Regulation; D055815:Young Adult
D001323:Autoantibodies; D053264:B-Cell Activating Factor; C114631:TNFSF13 protein, human; C505719:TNFSF13B protein, human; D053300:Tumor Necrosis Factor Ligand Superfamily Member 13; D005169:Factor VIII